Tag Archives: Tysabri (natalizumab) Drug Safety Communication

Tysabri (natalizumab) Drug Safety Communication

Share

translation servicesTranslate | French translation Spanish translation translate German translate Chinese Tysabri (natalizumab): Drug Safety Communication – New Risk Factor for Progressive Multifocal Leukoencephalopathy (PML) AUDIENCE: Neurology, Gastroenterology ISSUE: FDA notified healthcare profesisonals that testing positive for anti-JC virus (JCV) … Continue reading

Share
Posted in FDA 2012, FDA Notice, Gastroenterology, Neurology | Tagged , , , , , , , , | Comments Off